IRIS Accounts Production v24.2.0.383 06878233 director 1.5.23 30.4.24 30.4.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh068782332023-04-30068782332024-04-30068782332023-05-012024-04-30068782332022-04-30068782332022-05-012023-04-30068782332023-04-3006878233ns15:EnglandWales2023-05-012024-04-3006878233ns14:PoundSterling2023-05-012024-04-3006878233ns10:Director12023-05-012024-04-3006878233ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3006878233ns10:SmallEntities2023-05-012024-04-3006878233ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3006878233ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3006878233ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3006878233ns10:FullAccounts2023-05-012024-04-3006878233ns10:RegisteredOffice2023-05-012024-04-3006878233ns5:CurrentFinancialInstruments2024-04-3006878233ns5:CurrentFinancialInstruments2023-04-3006878233ns5:Non-currentFinancialInstruments2024-04-3006878233ns5:Non-currentFinancialInstruments2023-04-3006878233ns5:ShareCapital2024-04-3006878233ns5:ShareCapital2023-04-3006878233ns5:RetainedEarningsAccumulatedLosses2024-04-3006878233ns5:RetainedEarningsAccumulatedLosses2023-04-3006878233ns5:LandBuildings2023-05-012024-04-3006878233ns5:PlantMachinery2023-05-012024-04-3006878233ns5:LandBuildings2023-04-3006878233ns5:PlantMachinery2023-04-3006878233ns5:LandBuildings2024-04-3006878233ns5:PlantMachinery2024-04-3006878233ns5:LandBuildings2023-04-3006878233ns5:PlantMachinery2023-04-3006878233ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3006878233ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 06878233 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 April 2024

for

XL Medical Limited

XL Medical Limited (Registered number: 06878233)






Contents of the Financial Statements
for the Year Ended 30 April 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


XL Medical Limited

Company Information
for the Year Ended 30 April 2024







DIRECTOR: Dr N Waheed





REGISTERED OFFICE: 2 High Street
Burnham on Crouch
Essex
CM0 8AA





REGISTERED NUMBER: 06878233 (England and Wales)





ACCOUNTANTS: Harvey Smith & Co DVQ Limited
A Xeinadin Company
2 High Street
Burnham on Crouch
Essex
CM0 8AA

XL Medical Limited (Registered number: 06878233)

Balance Sheet
30 April 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,014,802 1,065,237

CURRENT ASSETS
Debtors 5 1,124 1,228
Cash at bank 66,427 34,719
67,551 35,947
CREDITORS
Amounts falling due within one year 6 106,156 103,562
NET CURRENT LIABILITIES (38,605 ) (67,615 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

976,197

997,622

CREDITORS
Amounts falling due after more than one
year

7

62,800

98,713
NET ASSETS 913,397 898,909

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 913,396 898,908
SHAREHOLDERS' FUNDS 913,397 898,909

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

XL Medical Limited (Registered number: 06878233)

Balance Sheet - continued
30 April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 January 2025 and were signed by:





Dr N Waheed - Director


XL Medical Limited (Registered number: 06878233)

Notes to the Financial Statements
for the Year Ended 30 April 2024

1. STATUTORY INFORMATION

XL Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis. This assumes that the company will continue in existence for the foreseeable future.

The validity of this assumption depends on the continued financial support of the directors and creditors.

If the company were unable to continue in operational existence, adjustments would have to be made to reduce the balance sheet values of assets to their recoverable amounts, and to provide for any further liabilities that might arise and to reclassify fixed assets as current assets. Long term liabilities would also have to be reclassified as current liabilities.

The directors believe that it is appropriate for the financial statements to be prepared on the going concern basis.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 2% on cost
Plant and machinery etc - 25% on cost and 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

XL Medical Limited (Registered number: 06878233)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 May 2023
and 30 April 2024 1,183,825 109,815 1,293,640
DEPRECIATION
At 1 May 2023 191,158 37,245 228,403
Charge for year 23,677 26,758 50,435
At 30 April 2024 214,835 64,003 278,838
NET BOOK VALUE
At 30 April 2024 968,990 45,812 1,014,802
At 30 April 2023 992,667 72,570 1,065,237

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 1,124 1,075
Other debtors - 153
1,124 1,228

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans and overdrafts 2,023 5,744
Hire purchase contracts 6,915 5,121
Trade creditors 6,856 129
Taxation and social security 42,859 32,150
Other creditors 47,503 60,418
106,156 103,562

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.4.24 30.4.23
£    £   
Bank loans 12,644 41,642
Hire purchase contracts 50,156 57,071
62,800 98,713

XL Medical Limited (Registered number: 06878233)

Notes to the Financial Statements - continued
for the Year Ended 30 April 2024

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued
30.4.24 30.4.23
£    £   
Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 4,552 18,667

8. RELATED PARTY DISCLOSURES

During the year, total dividends of £1,000 (2023 - £2,000) were paid to the director .

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Dr N Waheed.